GlassScriptPhysician profile
Atabak Allaei
NPI 1720390420
$5,632.72
in general payments reported to CMS, 2019-2025
13 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $137 · 2021: $885 · 2022: $3,090 · 2023: $978 · 2024: $49.32 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,238.30 | 2019-2023 | Indigo System |
| Boston Scientific Corporation | $1,387.73 | 2020-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Medtronic, INC. | $228.42 | 2021-2023 | Hawkone |
| Inari Medical, INC. | $193.13 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $179.59 | 2023-2024 | Spinejack, Optablate |
| Medical Device Business Services, INC. | $121.30 | 2019 | |
| Cook Medical LLC | $67.46 | 2019-2022 | |
| Angiodynamics, INC. | $50.22 | 2019-2020 | |
| Guerbet LLC | $40.82 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $38.64 | 2023 | Opsumit, Uptravi |
| Trisalus Life Sciences, INC. | $33.96 | 2023 | Trinav Infusion System |
| Teleflex LLC | $32.00 | 2023 | |
| Covidien LP | $21.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atabak Allaei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.